Galmed Pharmaceuticals Ltd. (GLMD) Has Soared To A New High On Study Results

Galmed Pharmaceuticals Ltd. (GLMD) reported results from its Phase 2 study of Aramchol 600mg Tuesday morning. The study demonstrated a statistically significant reduction in liver fat.

from RTT - Hot Stocks https://ift.tt/2JAsrEA
via IFTTT